Emalex Biosciences

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Health and bio

Acquired by TTeva Pharmaceuticals on April 29, 2026 for $700M · Yahoo Finance.

TIMELINE · MONEY RAISED

Emalex Biosciences | 2060 days on the record

Raised $285M in 2 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. April 29, 2026
   Acquired by TTeva Pharmaceuticals · $700M
   Source: Yahoo Finance
2. November 3, 2022
   Series B+ · $250M
   BBain Capital Life Sciences (lead), FFidelity, PParagon Biosciences, VValor Equity Partners
   Source: fundraisingfox.com
3. March 23, 2021
   Series B+ · $35M
   PParagon Biosciences (lead), FFidelity, VValor Equity Partners
   Source: finsmes.com
4. April 4, 2018
   Website created

Founders and team

• JA
  Jeff Aronin Founder

  @ParagonBiosci · LinkedIn
• AM
  Atul Mahableshwarkar Chief Medical Officer
• TR
  Timothy Rudolphi Chief Commercial Officer

Acquisitions

Acquired company	Price	Announced
PPsyadon Pharmaceuticals	Not disclosed publicly	Date not given

Investors

• BBain Capital Life Scienceslead investor
• FFidelity
• HHorizon Technology Finance
• PParagon Bioscienceslead investor
• VValor Equity Partners

Companies like Emalex Biosciences

• NNoema PharmaSeries B+ · Nov 2025
• AAzafaros$150M Series B+ · May 2025
• TTAVRA BiosciencesSeed · Apr 2026
• BBloom Science$12M Series A · Dec 2021
• SSleptaySeries A · Sep 2026
• HHolobiomeSeed · Jul 2026

Other companies backed by Bain Capital Life Sciences

• OOMass Therapeutics$310M Series B+ · Oct 2026
• AAdvanCell$315M Series B+ · Jul 2026
• AAngitia Bio$130M Series B+ · Feb 2026
• SSyremis Therapeutics$165M Series A · Dec 2025
• MMerida Biosciences$120M Series A · May 2025
• CCardurion Pharmaceuticals$260M Series B+ · Jul 2024

Bain Capital Life Sciences portfolio →